Delaware
|
1-11353
|
13-3757370
|
||
(State or other jurisdiction of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
358 South Main Street,
|
||||
Burlington, North Carolina
|
27215
|
336-229-1127
|
||
(Address of principal executive offices)
|
(Zip Code)
|
(Registrant’s telephone number including area code)
|
[ ]
|
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.01
|
Completion of Acquisition or Disposition of Assets
|
Item 9.01
|
Financial Statements and Exhibits
|
|
The Company has determined that financial statements are not required to be filed under this Item 9.01(a) pursuant to Rule 3-05(b) of Regulation S-X promulgated by the Securities and Exchange Commission (the "Commission").
|
|
The Company has determined that pro forma financial information is not required to be filed under this Item 9.01(b) pursuant to Article 11 of Regulation S-X promulgated by the Commission.
|
2.1
|
Asset Purchase Agreement by and among Genzyme Corporation and Laboratory Corporation of America Holdings dated as of September 13, 2010 (incorporated by reference from Exhibit 2.1 of the Company's Current Report on Form 8-K, filed with the Commission on September 16, 2010)
|
99.1
|
Press Release issued by the Company on December 1, 2010 (incorporated by reference from Exhibit 99.1 of the Company's Current Report on Form 8-K, filed with the Commission on December 1, 2010)
|
By:
|
/s/ F. SAMUEL EBERTS III
|
|
F. Samuel Eberts III
|
||
Chief Legal Officer and Secretary
|
2.1
|
Asset Purchase Agreement by and among Genzyme Corporation and Laboratory Corporation of America Holdings dated as of September 13, 2010 (incorporated by reference from Exhibit 2.1 of the Company's Current Report on Form 8-K, filed with the Commission on September 16, 2010)
|
99.1
|
Press Release issued by the Company on December 1, 2010 (incorporated by reference from Exhibit 99.1 of the Company's Current Report on Form 8-K, filed with the Commission on December 1, 2010)
|